Innovation and Entrepreneurship Awards winners announced

Dear Voornaam,

Last night, our innovation arm, Cancer Research Horizons, celebrated the oncology community at its Innovation and Entrepreneurship Awards, which recognises researchers and entrepreneurs bridging the gap between discoveries and positive patient outcomes.
Congratulations, everyone!
Early-career Entrepreneur of the Year: Jessica Corry Entrepreneurial Group Leader of the Year: Tim Witney Woman Entrepreneur of the Year: Natalie Mount New Startup of the Year: Trogenix Further, Faster, Together (Industry-Academia Collaboration): Cambridge Children's Hospital Innovation Hub
Four special awards recognised contributions to the academic cancer entrepreneurial field.
Entrepreneurship Recognition Award: Peter Parker Horizon Explorer Recognition Award: eDyNAmic Start-Up Achievement Recognition Award: Myricx Bio Translational Project of the Year Recognition Award: The Microsatellite Instability Plus (MSI-Plus) assay MGUS - A Rapid Platform for Integrated Monoclonal Protein Detection and Quantitation
“These remarkable innovators demonstrate the determination and collaborative spirit essential to transform scientific discoveries into real-world solutions. Their entrepreneurial leadership and drive shows what’s possible when excellence meets bold thinking, inspiring us all to accelerate progress and bring tangible benefit to people affected by cancer,” said Alessia Errico, Associate Director of Search and Evaluation at Cancer Research Horizons.
The winners were announced during a black-tie event at Merchant Taylors’ Hall in London, where rising stars met with seasoned entrepreneurs, industry experts and inspiring academics.

Can we find a ribosomal weakness in cancer?

Ribosomes are among the most common natural drug targets, yet they were long dismissed as a viable option in cancer treatment. Now, new insights are prompting a fresh look at this to better understand ribosome production and how it is altered in malignant cells.
In our latest article in Cancer News for Researchers, Faraz K. Mardakheh gives us a breakdown of this rich and underexplored landscape of therapeutic opportunity.

Snapshot of this year’s All Fellows meeting

We’re fresh off the back of our hugely successful All Fellows meeting held last week in Harrogate. We welcomed a mix of our funded fellows, programme foundation awardees and institute junior group leaders to meet each other and gain insights from our staff working across the breadth of our funding committees and our innovation arm, Cancer Research Horizons.
Our engaging speakers and facilitators led a value-packed agenda exploring the fantastic science our fellows are driving, potential solutions to challenges our fellows may face and inspiring sessions from patient and public representatives on involving patients in your research.
A huge thank you to everyone who was involved in making this an event to remember.

Take advantage of £80bn in funding from Horizon Europe

Horizon Europe is the world’s largest research and innovation programme running from 2021 until 2027. It supports a wide range of research and innovation objectives – meaning you could receive up to €20m per project via their health programme or up to €11m for research into cancer prevention and cures via their cancer mission.
Learn more about the funding programmes on offer and find out if there is an opportunity right for you.